Adial Pharmaceuticals Receives Notice of Allowance on the U.S. Patent for the Treatment for Opioid Use Disorder Using AD04 Adial Pharmaceuticals Receives Notice of Allowance on the U.S. Patent for the Treatment for Opioid Use Disorder Using AD04
